Division for Infectious Disease Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.
Surg Infect (Larchmt). 2013 Apr;14(2):188-91. doi: 10.1089/sur.2012.015. Epub 2013 Mar 26.
Antibiotic resistance is a global problem that affects the surgical patient population. Guidelines for antibiotic use have been shown to be effective both in terms of protecting individuals undergoing surgery and ensuring appropriate prescribing. More than 5,000 cholecystectomies are performed each year in Norway. However, there are no national guidelines for prophylactic antibiotics. The aim of this study was to chart the existence of local guidelines and whether they were updated and used. This was in order to inform practice and contribute to a rational approach to antibiotic prophylaxis for cholecystectomies.
An online questionnaire was sent to consultant surgeons from every hospital conducting cholecystectomies in Norway. Questions were related to the existence, content, and evaluation of any guidelines concerning prophylactic antibiotic treatment.
Thirty-seven of 47 hospitals responded. Overall, 17 of 37 had written guidelines, although this was higher in university hospitals (71%) than in local ones (39%). Not all hospitals with guidelines had them for both laparoscopic and open surgical methods. Most hospitals gave prophylaxis to patients undergoing open cholecystectomies. Guidelines for laparoscopic patients advised no prophylaxis in six institutions, four hospitals recommended prophylaxis of all their patients and others restricted their use to specific subpopulations. The majority with guidelines had revised their information within the last five years.
The presence and contents of guidelines vary greatly among Norwegian hospitals. Although many used guidelines to highlight at-risk patients needing antibiotics, there were cases that advocated antibiotics to patients where the benefit is doubtful. We recommend the establishment of a national protocol to optimize antibiotic use, raise awareness of resistance, and promote the treatment of patients at high risk of developing a health care-associated infection.
抗生素耐药性是一个全球性问题,影响着手术患者群体。抗生素使用指南已被证明在保护手术患者和确保合理处方方面都非常有效。挪威每年进行超过 5000 例胆囊切除术。然而,目前尚无预防性抗生素使用的国家指南。本研究旨在了解当地指南的存在情况,以及它们是否得到了更新和使用。这是为了告知实践并为胆囊切除术的抗生素预防提供合理方法。
向挪威所有进行胆囊切除术的医院的顾问外科医生发送了在线问卷。问题涉及有关预防性抗生素治疗的任何指南的存在、内容和评估。
47 家医院中有 37 家做出了回应。总体而言,有 17/37 家医院有书面指南,但大学医院(71%)高于地方医院(39%)。并非所有有指南的医院都有腹腔镜和开放式手术方法的指南。大多数医院对接受开放式胆囊切除术的患者进行预防。对于腹腔镜患者,有 6 家医院建议不进行预防,4 家医院建议对所有患者进行预防,其他医院则将其使用限制在特定亚人群。大多数有指南的医院在过去五年内更新了信息。
挪威各医院指南的存在和内容差异很大。尽管许多医院使用指南来突出需要抗生素的高危患者,但也有一些医院主张给那些受益不确定的患者使用抗生素。我们建议制定国家方案以优化抗生素使用,提高对抗生素耐药性的认识,并治疗发生医疗保健相关感染风险较高的患者。